Thomas Jefferson University

Kevin Zarrabi

TitleAsst Professor
InstitutionThomas Jefferson University
DepartmentMedical Oncology
Address1025 Walnut St.
Philadelphia PA 19107
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Hochberg AR, Gomella PT, Im B, Ghosh A, Shah S, Thompson RAM, Zarrabi KK, Shah MS, Mark JR, Izes JK, Lallas CD, Gomella LG, Metwalli AR. Is the TriNetX Database a Good Tool for Investigation of Real-World Management of Von Hippel-Lindau? J Kidney Cancer VHL. 2024; 11(4):28-38. PMID: 39678829.
      Citations:    
    2. Barata PC, Zarrabi KK, Bex A, Grivas P, Hermann K, Hofman MS, Li R, Lopez-Beltran A, Padani AR, Powles T, Taplin ME, Loriot Y. Novel Methods to Assess Tumor Burden and Minimal Residual Disease in Genitourinary Cancers. Eur Urol. 2024 Dec 04. PMID: 39638730.
      Citations:    
    3. Iskandar AS, Zarrabi KK, Tester WJ. Renal cell carcinoma: entering the age of biomarkers. Can J Urol. 2024 Aug; 31(4):11921-11930. PMID: 39217515.
      Citations:    
    4. Palecki J, Bhasin A, Bernstein A, Mille PJ, Tester WJ, Kelly WK, Zarrabi KK. T-Cell redirecting bispecific antibodies: a review of a novel class of immuno-oncology for advanced prostate cancer. Cancer Biol Ther. 2024 Dec 31; 25(1):2356820. PMID: 38801069.
      Citations:    
    5. Eturi A, Bhasin A, Zarrabi KK, Tester WJ. Predictive and Prognostic Biomarkers and Tumor Antigens for Targeted Therapy in Urothelial Carcinoma. Molecules. 2024 Apr 22; 29(8). PMID: 38675715.
      Citations:    
    6. Zarrabi KK, Miron B, Geynisman DM. Contemporary role of avelumab first-line maintenance in advanced urothelial carcinoma with consideration of the JAVELIN Bladder 100 comprehensive clinical subgroup analyses. Transl Androl Urol. 2024 Mar 31; 13(3):463-466. PMID: 38590958.
      Citations:    
    7. Zorko NA, Makovec A, Elliott A, Kellen S, Lozada JR, Arafa AT, Felices M, Shackelford M, Barata P, Zakharia Y, Narayan V, Stein MN, Zarrabi KK, Patniak A, Bilen MA, Radovich M, Sledge G, El-Deiry WS, Heath EI, Hoon DSB, Nabhan C, Miller JS, Hwang JH, Antonarakis ES. Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes. Prostate Cancer Prostatic Dis. 2024 Feb 28. PMID: 38418892.
      Citations:    
    8. Mar N, Dwabe S, Baranda MN, Zarrabi KK, Eturi A, Gulati S, Parikh M, Seyedin SN, Kalebasty AR. Therapy With Metronomic Cyclophosphamide (mCyc) for Previously-Treated Metastatic Castrate-Resistant Prostate Cancer (mCRPC). Clin Genitourin Cancer. 2023 Nov 07. PMID: 38087703.
      Citations:    
    9. Zarrabi KK, Narayan V, Mille PJ, Zibelman MR, Miron B, Bashir B, Kelly WK. Bispecific PSMA antibodies and CAR-T in metastatic castration-resistant prostate cancer. Ther Adv Urol. 2023 Jan-Dec; 15:17562872231182219. PMID: 37359737.
      Citations:    
    10. Sim?o DC, Zarrabi KK, Mendes JL, Luz R, Garcia JA, Kelly WK, Barata PC. Bispecific T-Cell Engagers Therapies in Solid Tumors: Focusing on Prostate Cancer. Cancers (Basel). 2023 Feb 23; 15(5). PMID: 36900202.
      Citations:    
    11. Zarrabi KK, Handorf E, Miron B, Zibelman MR, Anari F, Ghatalia P, Plimack ER, Geynisman DM. Comparative Effectiveness of Front-Line Ipilimumab and Nivolumab or Axitinib and Pembrolizumab in Metastatic Clear Cell Renal Cell Carcinoma. Oncologist. 2022 Oct 06. PMID: 36200791.
      Citations:    
    12. Zarrabi KK, Lanade O, Geynisman DM. Determining Front-Line Therapeutic Strategy for Metastatic Clear Cell Renal Cell Carcinoma. Cancers (Basel). 2022 Sep 22; 14(19). PMID: 36230530.
      Citations:    
    13. Miron B, Handorf E, Zarrabi K, Zibelman MR, Anari F, Ghatalia P, Plimack ER, Geynisman DM. Influence of first-line chemotherapy regimen on survival outcomes of patients with advanced urothelial carcinoma who received second-line immune checkpoint inhibitors. Urol Oncol. 2022 10; 40(10):454.e9-454.e16. PMID: 35788287.
      Citations:    
    14. Zarrabi KK, Galloway TJ, Flieder DB, Kumar SS, Judd J, Bauman JR. Assessing plasma circulating tumor human papillomavirus (HPV) DNA in determining treatment response in HPV-associated oropharyngeal cancer. Head Neck. 2022 08; 44(8):E25-E30. PMID: 35546490.
      Citations:    
    15. Shulman RM, Weinberg DS, Ross EA, Ruth K, Rall GF, Olszanski AJ, Helstrom J, Hall MJ, Judd J, Chen DYT, Uzzo RG, Dougherty TP, Williams R, Geynisman DM, Fang CY, Fisher RI, Strother M, Huelsmann E, Adige S, Whooley PD, Zarrabi K, Gupta B, Iyer P, McShane M, Yankey H, Lee CT, Burbure N, Laderman LE, Giurintano J, Reiss S, Horwitz EM. Adverse Events Reported by Patients With Cancer After Administration of a 2-Dose mRNA COVID-19 Vaccine. J Natl Compr Canc Netw. 2022 02; 20(2):160-166. PMID: 35130494.
      Citations:    
    16. Goolsarran N, Zarrabi K, Garcia C. Using a resident-led patient safety quality council to educate future QI leaders. Med Educ Online. 2021 Dec; 26(1):1855699. PMID: 33978560.
      Citations:    
    17. Zarrabi K, Walzer E, Zibelman M. Immune Checkpoint Inhibition in Advanced Non-Clear Cell Renal Cell Carcinoma: Leveraging Success from Clear Cell Histology into New Opportunities. Cancers (Basel). 2021 Jul 21; 13(15). PMID: 34359554.
      Citations:    
    18. Zarrabi K, Cummings K, Lum N, Taub E, Goolsarran N. A resident-led initiative to improve patient safety event reporting in an internal medicine residency program. J Community Hosp Intern Med Perspect. 2020 May 21; 10(2):111-116. PMID: 32850045.
      Citations:    
    19. Zarrabi K, Masic S, Schaefer C, Bartel MJ, Kutikov A, Zibelman M. Neoadjuvant checkpoint inhibition in renal cell carcinoma associated Stauffer's syndrome. Urol Case Rep. 2020 Mar; 29:101077. PMID: 31853444.
      Citations:    
    20. Zarrabi K, Paroya A, Wu S. Emerging therapeutic agents for genitourinary cancers. J Hematol Oncol. 2019 09 04; 12(1):89. PMID: 31484560.
      Citations:    
    21. Zarrabi K, Gemmill JAL, Safaee M, Baer L. Managing dermatologic changes of targeted cancer therapy. J Fam Pract. 2019 Jul/Aug; 68(6):334-340. PMID: 31381621.
      Citations:    
    22. Farooq F, Zarrabi K, Sweeney K, Kim J, Bandovic J, Patel C, Choi M. Multiregion Comprehensive Genomic Profiling of a Gastric Mixed Neuroendocrine-Nonneuroendocrine Neoplasm with Trilineage Differentiation. J Gastric Cancer. 2018 Jun; 18(2):200-207. PMID: 29984070.
      Citations:    
    23. Zhang Y, Zarrabi K, Hou W, Madajewicz S, Choi M, Zucker S, Chen WT. Assessing Clinical Outcomes in Colorectal Cancer with Assays for Invasive Circulating Tumor Cells. Biomedicines. 2018 Jun 06; 6(2). PMID: 29882767.
      Citations:    
    24. Zarrabi K, Wu S. An evaluation of nivolumab for the treatment of metastatic renal cell carcinoma. Expert Opin Biol Ther. 2018 06; 18(6):695-705. PMID: 29782188.
      Citations:    
    25. Zarrabi K, Wu S. Current and Emerging Therapeutic Targets for Metastatic Renal Cell Carcinoma. Curr Oncol Rep. 2018 04 02; 20(5):41. PMID: 29611002.
      Citations:    
    26. Zarrabi K, Wu S. Risk of Liver Toxicity with Nivolumab Immunotherapy in Cancer Patients. Oncology. 2018; 94(5):259-273. PMID: 29539626.
      Citations:    
    27. Rao Q, Schuster I, Seoud T, Zarrabi K, Goolsarran N. A Patient with Nafcillin-Associated Drug-Induced Liver Failure. Case Rep Gastroenterol. 2017 Sep-Dec; 11(3):564-568. PMID: 29033779.
      Citations:    
    28. Zarrabi K, Choy T, Sweeney K, Desai V, Keresztes R. Paraneoplastic edematous dermatomyositis: A rare syndrome observed in a case of small cell lung cancer. Clin Pract. 2017 Sep 15; 7(4):982. PMID: 29138685.
      Citations:    
    29. Zarrabi K, Fang C, Wu S. New treatment options for metastatic renal cell carcinoma with prior anti-angiogenesis therapy. J Hematol Oncol. 2017 02 02; 10(1):38. PMID: 28153029.
      Citations:    
    30. Zarrabi K, Desai V, Yim B, Gabig TG. Primary Diffuse Large B-Cell Lymphoma Localized to the Lacrimal Sac: A Case Presentation and Review of the Literature. Case Rep Hematol. 2016; 2016:5612749. PMID: 27672460.
      Citations:    
    31. Evensen NA, Kuscu C, Nguyen HL, Zarrabi K, Dufour A, Kadam P, Hu YJ, Pulkoski-Gross A, Bahou WF, Zucker S, Cao J. Unraveling the role of KIAA1199, a novel endoplasmic reticulum protein, in cancer cell migration. J Natl Cancer Inst. 2013 Sep 18; 105(18):1402-16. PMID: 23990668.
      Citations:    
    32. Nguyen HL, Zucker S, Zarrabi K, Kadam P, Schmidt C, Cao J. Oxidative stress and prostate cancer progression are elicited by membrane-type 1 matrix metalloproteinase. Mol Cancer Res. 2011 Oct; 9(10):1305-18. PMID: 21849471.
      Citations:    
    33. Zarrabi K, Dufour A, Li J, Kuscu C, Pulkoski-Gross A, Zhi J, Hu Y, Sampson NS, Zucker S, Cao J. Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration. J Biol Chem. 2011 Sep 23; 286(38):33167-77. PMID: 21795678.
      Citations:    
    34. Cao J, Chiarelli C, Richman O, Zarrabi K, Kozarekar P, Zucker S. Membrane type 1 matrix metalloproteinase induces epithelial-to-mesenchymal transition in prostate cancer. J Biol Chem. 2008 Mar 07; 283(10):6232-40. PMID: 18174174.
      Citations:    
    Zarrabi's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (114)
    Explore
    _
    Co-Authors (10)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _